Neurogene (NGNE) Stock Statistics & Valuation Metrics

Neurogene has a market cap or net worth of $298.36M. The enterprise value is $53.21M.

Neurogene has 14,262,066 shares outstanding. The number of shares has decreased by -2.65% in one year.

Neurogene’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -25.53%.

The current PE Ratio of Neurogene is -5.34. Neurogene’s PEG ratio is >-0.01.

In the last 12 months, Neurogene had revenue of 925.00K and earned -75.14M in profits. Earnings per share was -4.43.

In the last 12 months, operating cash flow was -69.73M and capital expenditures -1.52M, giving a free cash flow of -71.25M billion.

Neurogene pays an annual dividend of ―, resulting in a dividend yield of ―

Neurogene upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.

Neurogene as a current ratio of 20.84, with Debt / Equity ratio of -3.22%

In the past 12 months, Neurogene has paid 0.00 in taxes.

Neurogene EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -3.88.

Neurogene has $292.60M in cash and marketable securities with $13.54M in debt, giving a net cash position of -$279.06M billion.

Gross margin is 0.00%, with operating margin of -8930.27%, and net profit margin of -8123.68%.

The average price target for Neurogene is $35.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy